ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

Group Chairmen Criticize NCI Budget Priorities

July 11, 2003

NIH director; Targets Increases Favor Established Researchers

May 9, 1997

“Significant changes should be made to reduce redundancy, streamline operations, promote collaboration, and optimize productivity.”

July 14, 1995

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

June 9, 2006

AACR Statement on Precancers Plays Key Role in NCI Agenda

May 30, 2003

In Brief: Top Priority: Keep Rauscher; Pay Raise Bill No Moving; Miller, Holland Head AACR, ASCO

May 21, 1976